Patents by Inventor Atsunari KAWASHIMA

Atsunari KAWASHIMA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating cancer with an anti-CCR8 that binds tumor infiltrating cells
    Patent number: 11932696
    Abstract: The present invention provides a pharmaceutical composition for cancer treatment comprising an antibody against CCR8.
    Type: Grant
    Filed: December 28, 2020
    Date of Patent: March 19, 2024
    Assignees: SHIONOGI & CO., LTD., OSAKA UNIVERSITY
    Inventors: Tetsuya Yoshida, Yujiro Kidani, Mitsunobu Matsumoto, Takayuki Kanazawa, Satomi Shinonome, Kanji Hojo, Naganari Ohkura, Shimon Sakaguchi, Atsushi Tanaka, Hisashi Wada, Atsunari Kawashima, Norio Nonomura
  • MOLECULAR CLASSIFIERS FOR PROSTATE CANCER
    Publication number: 20230105654
    Abstract: There is described herein a method of predicting disease progression risk in a subject with prostate cancer, the method comprising: a) providing a sample containing RNA and DNA material from tumour cells; b) determining or measuring values for substantially all of patient features listed for PRONTO-e or PRONTO-m in Table 6, and some or all reference or control features set forth in Table 6; c) comparing said patient features to the reference or control features; and d) computing a prediction score using a classifier that takes said patient feature values as input, the classifier having been previously trained on samples from a population of early prostate cancer patients.
    Type: Application
    Filed: June 18, 2021
    Publication date: April 6, 2023
    Inventors: John BARTLETT, David BERMAN, Paul BOUTROS, Jacques LAPOINTE, Axel THOMSON, Vasundara VENKATESWARAN, Ralph BUTTYAN, Simone CHEVALIER, Nadia BOUFAIED, John OKELLO, Palak PATEL, Atsunari KAWASHIMA, Anna YING-WAH LEE, Robert LESURF, Jane BAYANI, Linh NGUYEN, Paul PARK, Walead EBRAHIMIZADEH
  • Novel Anti-CCR8 Antibody
    Publication number: 20220064312
    Abstract: Disclosed is a novel anti-CCR8 antibody. The antibody can be used for treating or preventing cancers or the like.
    Type: Application
    Filed: December 27, 2019
    Publication date: March 3, 2022
    Applicants: Shionogi & Co., Ltd., Osaka University
    Inventors: Mai Yoshikawa, Tatsuya Takahashi, Junji Onoda, Sunao Imai, Etsuo Nakamura, Kentaro Furukawa, Tsuguo Miyauchi, Tetsuya Yoshida, Morio Nagira, Naganari Ohkura, Atsushi Tanaka, Shimon Sakaguchi, Hisashi Wada, Atsunari Kawashima
  • Prostate Cancer Biomarker Assays
    Publication number: 20220002811
    Abstract: A multi-gene model is employed in methods for accurately classifying benign and malignant prostate cancer and reliably identifying prostate cancer in samples, with false positive and negative rates below 7%. A single gene model is employed in methods for detecting aggressive prostate cancer, prostate cancer patients at risk of developing biochemical recurrence, and prostate cancer patients suitable for treatment with an additional and/or alternative therapy. The methods may be implemented with next generation sequencing (NGS) or methylation-specific PCR (MSP). The MSP may use a mastermix specifically designed for use with bisulfite converted DNA in singleplex and multiplex assays.
    Type: Application
    Filed: October 1, 2019
    Publication date: January 6, 2022
    Inventors: David M. Berman, Palak Patel, John B.A. Okello, Robert Gooding, Atsunari Kawashima
  • Pharmaceutical Composition for Cancer Treatment
    Publication number: 20210115148
    Abstract: The present invention provides a pharmaceutical composition for cancer treatment comprising an antibody against CCR8.
    Type: Application
    Filed: December 28, 2020
    Publication date: April 22, 2021
    Applicants: Shionogi & Co., Ltd., Osaka University
    Inventors: Tetsuya Yoshida, Yujiro Kidani, Mitsunobu Matsumoto, Takayuki Kanazawa, Satomi Shinonome, Kanji Hojo, Naganari Ohkura, Shimon Sakaguchi, Atsushi Tanaka, Hisashi Wada, Atsunari Kawashima, Norio Nonomura
  • Pharmaceutical Composition for Cancer Treatment
    Publication number: 20210047421
    Abstract: The present invention provides a pharmaceutical composition for cancer treatment comprising an antibody against CCR8.
    Type: Application
    Filed: October 30, 2020
    Publication date: February 18, 2021
    Applicants: Shionogi & Co., Ltd., Osaka University
    Inventors: Tetsuya Yoshida, Yujiro Kidani, Mitsunobu Matsumoto, Takayuki Kanazawa, Satomi Shinonome, Kanji Hojo, Naganari Ohkura, Shimon Sakaguchi, Atsushi Tanaka, Hisashi Wada, Atsunari Kawashima, Norio Nonomura
  • Pharmaceutical Composition for Cancer Treatment
    Publication number: 20200232973
    Abstract: The disclosure provides a method of measuring an efficacy of a drug composition for cancer and a method for treating a cancer by administering to a subject an effective amount of a pharmaceutical composition having a polypeptide that binds to a peptide produced by cDNA of GenBank ACC No. NM_005201.3 or NM_007720.2.
    Type: Application
    Filed: January 2, 2020
    Publication date: July 23, 2020
    Applicants: Shionogi & Co., Ltd., Osaka University
    Inventors: Tetsuya Yoshida, Yujiro Kidani, Mitsunobu Matsumoto, Takayuki Kanazawa, Satomi Shinonome, Kanji Hojo, Naganari Ohkura, Shimon Sakaguchi, Atsushi Tanaka, Hisashi Wada, Atsunari Kawashima, Norio Nonomura
  • Pharmaceutical Composition for Cancer Treatment
    Publication number: 20200222463
    Abstract: The disclosure provides a pharmaceutical composition with a polypeptide that binds to a peptide produced by cDNA of GenBank ACC No. NM_005201.3 or NM_007720.2, and methods of use thereof.
    Type: Application
    Filed: January 2, 2020
    Publication date: July 16, 2020
    Applicants: Shionogi & Co., Ltd., Osaka University
    Inventors: Tetsuya Yoshida, Yujiro Kidani, Mitsunobu Matsumoto, Takayuki Kanazawa, Satomi Shinonome, Kanji Hojo, Naganari Ohkura, Shimon Sakaguchi, Atsushi Tanaka, Hisashi Wada, Atsunari Kawashima, Norio Nonomura
  • Method of treating cancer with an anti-CCR8 having antibody-dependent cell-mediated cytotoxicity (ADCC) activity against cells expressing CCR8
    Patent number: 10550191
    Abstract: The present invention provides a pharmaceutical composition for cancer treatment comprising an antibody against CCR8.
    Type: Grant
    Filed: November 7, 2018
    Date of Patent: February 4, 2020
    Assignees: Shionogi & Co., Ltd., Osaka University
    Inventors: Tetsuya Yoshida, Yujiro Kidani, Mitsunobu Matsumoto, Takayuki Kanazawa, Satomi Shinonome, Kanji Hojo, Naganari Ohkura, Shimon Sakaguchi, Atsushi Tanaka, Hisashi Wada, Atsunari Kawashima, Norio Nonomura
  • PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT
    Publication number: 20190071508
    Abstract: The present invention provides a pharmaceutical composition for cancer treatment comprising an antibody against CCR8.
    Type: Application
    Filed: November 7, 2018
    Publication date: March 7, 2019
    Applicants: SHIONOGI & CO., LTD., OSAKA UNIVERSITY
    Inventors: Tetsuya YOSHIDA, Yujiro KIDANI, Mitsunobu MATSUMOTO, Takayuki KANAZAWA, Satomi SHINONOME, Kanji HOJO, Naganari OHKURA, Shimon SAKAGUCHI, Atsushi TANAKA, Hisashi WADA, Atsunari KAWASHIMA, Norio NONOMURA